MMP9 and chronic inflammatory demyelinating polyradiculoneuropathy: However, a recent study showed the plasmatic pattern of matrix metalloproteinases (MMPs), especially MMP-9 and MMP-2 and their physiological tissue inhibitors, which are markedly altered in patients with CIDP [30].